News Conference News HRS 2024 CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation L.A. McKeown May 23, 2024
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Conference News ACC 2024 PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE L.A. McKeown April 08, 2024
News Daily News Antihypertensives Linked to Lower Long-term Dementia Risk Caitlin E. Cox April 01, 2024
News Conference News ACC 2024 Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT Todd Neale March 27, 2024
News Conference News Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality Michael O'Riordan March 22, 2024
News Daily News Patients With CKD Remain Underrepresented in Trials of CV Meds Todd Neale March 08, 2024
News Daily News DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients Michael O'Riordan March 04, 2024
News Daily News Living Near Bars, Restaurants Linked to Greater Likelihood of HF L.A. McKeown February 29, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News One in Three Overweight MI Patients May Benefit From Semaglutide Todd Neale February 26, 2024
News Daily News Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level Yael L. Maxwell February 15, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024